Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Xos Trucks specializes in the field of manufacturing fully electric commercial vehicles.
PepGen is empowering nucleic acid therapeutics to go the distance.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Forte Biosciences is a biotechnology company that focuses on dermatology.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars.
Wallbox is a technology company that provides electric vehicle charging and energy management solutions.
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 25 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post Ipo Equity round. Janus Henderson Investors's total known invested capital is $35.8B.
Janus Henderson Investors's average investment size is $153.6M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Kailera Therapeutics, Biomea Fusion, Star Therapeutics, Xos Trucks, Pepgen. These companies were founded in 2020 or later.